Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Tract Infections | 2 | 2022 | 39 | 0.970 |
Why?
|
Emergency Service, Hospital | 5 | 2023 | 117 | 0.790 |
Why?
|
Penile Diseases | 1 | 2021 | 9 | 0.740 |
Why?
|
Penis | 1 | 2021 | 16 | 0.740 |
Why?
|
Urinary Bladder | 1 | 2021 | 118 | 0.740 |
Why?
|
Anemia, Sickle Cell | 3 | 2023 | 37 | 0.560 |
Why?
|
Child | 11 | 2024 | 2146 | 0.500 |
Why?
|
Bacteremia | 3 | 2022 | 80 | 0.470 |
Why?
|
Child, Preschool | 7 | 2024 | 1090 | 0.460 |
Why?
|
Patient Admission | 1 | 2013 | 28 | 0.440 |
Why?
|
Meningitis, Bacterial | 2 | 2022 | 9 | 0.400 |
Why?
|
Influenza B virus | 1 | 2011 | 3 | 0.390 |
Why?
|
Body Mass Index | 1 | 2013 | 386 | 0.390 |
Why?
|
Pediatric Emergency Medicine | 2 | 2023 | 3 | 0.380 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 42 | 0.370 |
Why?
|
Influenza, Human | 1 | 2011 | 84 | 0.360 |
Why?
|
Infant | 8 | 2024 | 957 | 0.330 |
Why?
|
Male | 11 | 2024 | 12868 | 0.310 |
Why?
|
Status Asthmaticus | 1 | 2007 | 1 | 0.290 |
Why?
|
Terbutaline | 1 | 2007 | 1 | 0.290 |
Why?
|
Albuterol | 1 | 2007 | 4 | 0.290 |
Why?
|
Bronchodilator Agents | 1 | 2007 | 15 | 0.290 |
Why?
|
Sodium Chloride | 1 | 2007 | 65 | 0.280 |
Why?
|
Humans | 15 | 2024 | 26828 | 0.240 |
Why?
|
Adolescent | 6 | 2024 | 2955 | 0.240 |
Why?
|
Retrospective Studies | 4 | 2021 | 2429 | 0.230 |
Why?
|
Female | 9 | 2024 | 14456 | 0.220 |
Why?
|
Pain | 3 | 2023 | 252 | 0.220 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 7 | 0.210 |
Why?
|
Otitis Media | 2 | 2020 | 35 | 0.200 |
Why?
|
Bacterial Infections | 1 | 2022 | 54 | 0.200 |
Why?
|
Urine Specimen Collection | 1 | 2021 | 2 | 0.200 |
Why?
|
Urinary Catheterization | 1 | 2021 | 15 | 0.200 |
Why?
|
Urine | 1 | 2021 | 14 | 0.200 |
Why?
|
Rupture | 1 | 2021 | 11 | 0.190 |
Why?
|
Lymphadenitis | 1 | 2020 | 1 | 0.190 |
Why?
|
Prospective Studies | 3 | 2024 | 1216 | 0.190 |
Why?
|
Oklahoma | 3 | 2013 | 973 | 0.180 |
Why?
|
Urethra | 1 | 2021 | 33 | 0.180 |
Why?
|
Pain Management | 1 | 2019 | 52 | 0.160 |
Why?
|
Vascular Diseases | 1 | 2019 | 67 | 0.150 |
Why?
|
Hospitals, University | 2 | 2013 | 26 | 0.140 |
Why?
|
Hospitals, Pediatric | 2 | 2013 | 30 | 0.120 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 10 | 0.110 |
Why?
|
Cellulitis | 1 | 2013 | 7 | 0.110 |
Why?
|
Thinness | 1 | 2013 | 17 | 0.110 |
Why?
|
Skin Diseases, Bacterial | 1 | 2013 | 9 | 0.110 |
Why?
|
Bacteriological Techniques | 1 | 2013 | 18 | 0.110 |
Why?
|
Soft Tissue Infections | 1 | 2013 | 10 | 0.110 |
Why?
|
Blood | 1 | 2013 | 33 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2013 | 34 | 0.110 |
Why?
|
Malnutrition | 1 | 2013 | 30 | 0.110 |
Why?
|
Nervous System Diseases | 1 | 2013 | 39 | 0.110 |
Why?
|
Abscess | 1 | 2013 | 24 | 0.110 |
Why?
|
Risk | 1 | 2013 | 133 | 0.110 |
Why?
|
Fractures, Bone | 1 | 2013 | 43 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2013 | 72 | 0.110 |
Why?
|
Comorbidity | 1 | 2013 | 252 | 0.100 |
Why?
|
Overweight | 1 | 2013 | 110 | 0.100 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2012 | 9 | 0.100 |
Why?
|
Infratentorial Neoplasms | 1 | 2012 | 4 | 0.100 |
Why?
|
Nerve Compression Syndromes | 1 | 2012 | 10 | 0.100 |
Why?
|
Blepharoptosis | 1 | 2012 | 7 | 0.100 |
Why?
|
Lipoma | 1 | 2012 | 11 | 0.100 |
Why?
|
Medical Audit | 1 | 2011 | 15 | 0.100 |
Why?
|
Wounds and Injuries | 1 | 2013 | 166 | 0.090 |
Why?
|
Infant, Newborn | 2 | 2024 | 844 | 0.080 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 910 | 0.080 |
Why?
|
Administration, Inhalation | 1 | 2007 | 34 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 801 | 0.070 |
Why?
|
Infusions, Intravenous | 1 | 2007 | 99 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 203 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2007 | 399 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 586 | 0.060 |
Why?
|
United States | 2 | 2022 | 2031 | 0.060 |
Why?
|
Urinalysis | 1 | 2022 | 10 | 0.050 |
Why?
|
Research Design | 1 | 2024 | 174 | 0.050 |
Why?
|
Fentanyl | 1 | 2023 | 31 | 0.050 |
Why?
|
Fever | 1 | 2022 | 30 | 0.050 |
Why?
|
Patient Discharge | 1 | 2023 | 96 | 0.050 |
Why?
|
Crying | 1 | 1981 | 1 | 0.050 |
Why?
|
Community Health Nursing | 1 | 1981 | 3 | 0.050 |
Why?
|
Cohort Studies | 1 | 2024 | 859 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 102 | 0.050 |
Why?
|
Spain | 1 | 2020 | 15 | 0.050 |
Why?
|
Drug Utilization | 1 | 2020 | 28 | 0.050 |
Why?
|
Canada | 1 | 2020 | 58 | 0.050 |
Why?
|
Treatment Outcome | 1 | 2007 | 2262 | 0.050 |
Why?
|
Parents | 1 | 1981 | 121 | 0.050 |
Why?
|
Adult | 2 | 2024 | 7381 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 189 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2018 | 4 | 0.040 |
Why?
|
Staff Development | 1 | 2018 | 7 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 2580 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 496 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 279 | 0.030 |
Why?
|
Soft Tissue Injuries | 1 | 2013 | 5 | 0.030 |
Why?
|
Wound Infection | 1 | 2013 | 13 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 104 | 0.030 |
Why?
|
Skin | 1 | 2013 | 140 | 0.030 |
Why?
|
Length of Stay | 1 | 2013 | 215 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2012 | 8 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2012 | 27 | 0.030 |
Why?
|
Emergencies | 1 | 2012 | 28 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 51 | 0.020 |
Why?
|
Asthma | 1 | 2012 | 57 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 465 | 0.020 |
Why?
|
Midwifery | 1 | 1981 | 3 | 0.010 |
Why?
|
Telephone | 1 | 1981 | 25 | 0.010 |
Why?
|
Home Care Services | 1 | 1981 | 37 | 0.010 |
Why?
|